Apoptosis of tubulointerstitial chronic inflammatory cells in progressive renal fibrosis after cancer therapies

Translational Research

Volumn 150, Issue 1, 2007, Pages 40-50

  Yang, Tao ^a   Vesey, David A ^b   Johnson, Davin W ^b   Wei, Ming Q ^a   Gobe, Glenda C ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL COUNT; CELL DEATH; CELL POPULATION; CONTROLLED STUDY; FIBROGENESIS; INFLAMMATORY CELL; INTERSTITIAL NEPHRITIS; KIDNEY CANCER; KIDNEY FIBROSIS; MALE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RADIATION DOSE; RAT; TISSUE SECTION;

EID: 34250696909     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2007.01.006     Document Type: Article

References (40)

1. Eddy A.A. Progression in chronic kidney disease. Adv Chronic Kidney Dis 12 (2005) 353-365
2. Young B., Burdmann E., Johnson R., Alpers C., Giachelli C., Eng E., et al. Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int 48 (1995) 439-448
3. Hewitson T., Wu H.-L., and Becker G. Interstitial myofibroblasts in experimental renal infection and scarring. Am J Nephrol 15 (1999) 411-417
4. Ide M., Yamate J., Kuwamura M., Kotani T., Sakuma S., and Takeya M. Immunohistochemical analysis of macrophages and myofibroblasts appearing in hepatic and renal fibrosis of dogs. J Comp Pathol 124 (2001) 60-69
5. Yamate J., Sato K., Ide M., Nakanishi M., Kuwamura M., Sakuma S., et al. Participation of different macrophage populations and myofibroblast cells in chronically developed interstitial fibrosis after cisplatin-induced renal injury in rats. Vet Pathol 39 (2002) 322-333
6. Lane A., Johnson D.W., Pat B., Zhang X.-J., Cuttle L., Winterford C., et al. Myofibroblast apoptosis and growth factors in development and progression of renal tubulo-interstitial fibrosis in the rat. Growth Factors 20 (2002) 109-119
7. Chow F.Y., Nikolic-Paterson D.J., Atkins R.C., and Tesch G.H. Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol Dial Transplant 19 (2004) 2987-2996
8. Goumenos D., Tsamandas A., Oldroyd S., Sotsiou F., Tsakas S., Petropoulou C., et al. Transforming growth factor-β1 and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease. Nephron 87 (2001) 240-248
9. Qi W., Chen X., Holian J., Mreich E., Twigg S., Gilbert R.E., et al. Transforming growth factor-beta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells. Am J Physiol Renal Physiol 291 (2006) F1070-F1077
10. Vesey D., Cheung C., Cuttle L., Endre Z., Gobe G., and Johnson D.W. Interleukin-1β induces human proximal tubule injury, α-smooth muscle actin expression and fibronectin production. Kidney Int 62 (2002) 31-40
11. Gobe G., and Axelsen R. The role of apoptosis in the development of renal cortical tubular atrophy associated with healed experimental renal papillary necrosis. Pathology 23 (1991) 213-223
12. Lieberthal W., Triaca V., and Levine J. Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am J Physiol 270 (1996) F700-F708
13. Thomas G.L., Yang B., Wagner B.E., Savill J., and El Nahas A.M. Cellular apoptosis and proliferation in experimental renal fibrosis. Nephrol Dial Transplant 13 (1998) 2216-2226
14. Schrama J., Holtkamp M., Baars J., Schornagel J., and Rodenhuis S. Toxicity of the high dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin). The Netherlands Cancer Institute experience. Br J Cancer 88 (2003) 1831-1838
15. Hartmann J., Kollmannsberger C., Kanz L., and Bokemeyer C. Platinum organ toxicity and possible prevention in patients with testicular cancer. Int J Cancer 83 (1999) 866-869
16. Robbins M., O'Malley Y., Zhao W., Davis C., and Bonsib S. The role of the tubulointerstitium in radiation-induced fibrosis. Radiat Res 155 (2001) 481-489
17. Robbins M., Zhao W., Davis C., Toyokuni S., and Bonsib S. Radiation-induced kidney injury: a role for chronic oxidative stress. Micron 33 (2002) 133-141
18. Lawton C., Cohen E., Barber-Derus S., Murray K., Ash R., Casper J., et al. Late renal dysfunction in survivors of bone marrow transplantation. Cancer 67 (1991) 2795-2800
19. Oyama Y., Komatsuda A., Imai H., Ohtani H., Hamia K., Wakui H., et al. Late onset bone marrow transplant nephropathy. Intern Med 35 (1996) 489-493
20. Cohen E.P., Piering W.F., Kabler-Babbitt C., and Moulder J.E. End stage renal disease after bone marrow transplantation: poor survival compared with other causes of ESRD. Nephron 79 (1998) 408-412
21. Yamate J., Tatsumi M., Nakatsuji S., Kuwamura M., Kotani T., and Sakuma S. Immunohistochemical observations on the kinetics of macrophages and myofibroblasts in rat renal interstitial fibrosis induced by cis-diamminedichloroplatinum. J Comp Pathol 112 (1995) 27-39
22. Gobe G., Willgoss D., Schoch E., Hogg N., and Endre Z. Relationship between Bcl-2 genes, growth factors and apoptosis in acute ischemic renal injury in the rat. J Am Soc Nephrol 11 (2000) 454-467
23. Kerr J.F.R., Gobe G.C., Winterford C., and Harmon B.V. Anatomical methods in cell death. Meth Cell Biol 46 (1995) 1-27
24. Ng Y.Y., Huang T., Yang W.C., Chen Z.P., Yang A.H., Mu W., et al. Tubular epithelial-myofibroblast transdifferentiation in progressive TIF in 5/6 nephrectomized rats. Kidney Int 54 (1998) 864-876
25. Wang S., Denichilo M., Brubaker C., and Hirschberg R. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney Int 60 (2001) 96-105
26. Goumenos D., Tsamandas A., El Nahas A., Thomas G., Tsakas S., Sotsiou F., et al. Apoptosis and myofibroblast expression in human glomerular disease: a possible link with transforming growth factor-β1. Nephron 92 (2002) 287-296
27. Yokoi H., Mukoyama M., Nagae T., Mori K., Suganami T., Sawai K., et al. Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol 15 (2004) 1430-1440
28. Eddy A.A. Can renal fibrosis be reversed?. Pediatr Nephrol 20 (2005) 1369-1375
29. Shimizu A., Kitamura H., Masuda Y., Ishizaki M., Sugisaki Y., and Yamanaka N. Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 47 (1995) 114-121
30. Desmouliere A., Geinoz A., Gabriani F., and Gabbiani G. Transforming growth factor-beta1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultures fibroblasts. J Cell Biol 122 (1993) 103-111
31. Tang W., Ulich T., Lacey D., Hill D., Qi M., Kaufman S., Van G., Tarpley J., and Yee J. Platelet derived growth factor (PDGF)-BB induces tubulointerstitial myofibroblast formation, and tubulointerstitial fibrosis. Am J Pathol 148 (1996) 1169-1180
32. Gabbiani G. The cellular derivation and life span of the myofibroblast. Pathol Res Pract 192 (1996) 708-711
33. Grupp C., Lottermoser J., Cohen D., Begher M., Franz H.-E., and Muller G. Transformation of rat inner medullary fibroblasts to myofibroblasts in vitro. Kidney Int 52 (1997) 1279-1290
34. Ito Y., Aten J., Bende R., Oemar B., Rabelink T., Weening J., et al. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53 (1998) 853-861
35. Yokoi H., Sugawara A., Mukoyama M., Mori K., Makino H., Suganami T., et al. Role of connective tissue growth factor in profibrotic action of transforming growth factor-β: a potential target for preventing renal fibrosis. Am J Kidney Dis 38 (2001) S134-S138
36. Inoue T., Okada H., Kobayashi T., Watanabe Y., Kanno Y., Kopp J., et al. Hepatocyte growth factor counteracts transforming growth factor β1, through attenuation of connective tissue growth factor induction, and prevents renal fibrosis in 5/6 nephrectomised mice. FASEB J 17 (2003) 268-270
37. Fukasawa H., Yamamoto T., Suzuki H., Togawa A., Ohashi N., Fujigaki Y., et al. Treatment with anti-TGF-β antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-β signalling. Kidney Int 65 (2004) 63-74
38. Johnson D.W., Saunders H.J., Baxter R.C., Field M., and Pollock C.A. Paracrine stimulation of human renal fibroblasts by proximal tubule cells. Kidney Int 54 (1998) 747-757
39. Bussolati B., David S., Cambi V., Tobais P., and Camussi G. Urinary soluble CD14 mediates human proximal tubular epithelial injury induced by LPS. Int J Mol Med 10 (2002) 441-449
40. Awad A.S., Huang L., Ye H., Duong E.T., Bolton W.K., Linden J., et al. Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy. Am J Physiol Renal Physiol 290 (2006) F828-F837